ALGN vs IDXX
Align Technology vs Idexx Laboratories — AI-powered side-by-side comparison
ALGN
Align Technology
62
Buy
VS
IDXX
Idexx Laboratories
62
Buy
| Metric | ALGN | IDXX |
|---|
| AI Score |
62
|
62
|
| Price |
$173.70
|
$586.77
|
| P/E Ratio |
30.15×
|
41.20×
|
| ROE |
10.1%
|
66.0%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
66.5%
|
62.4%
|
| Debt / Equity |
0.03×
|
0.60×
|
| Dividend Yield |
0.0%
|
0.0%
|
| RSI (14) |
50.8
|
65.3
|
| Beta |
1.669
|
1.549
|
| Expected Upside |
+9.2%
|
+12.3%
|
AI Committee View
Current Innellis committee reasoning for ALGN versus IDXX.
The committee scores are tied.
ALGN and IDXX both score 62/100.
ALGN Committee View
50% agreement
6 analysts
The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.
Bull Case
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Weekly trend (sideways) confirms the daily trend -- multi-timeframe agreement — Technical
- Low leverage (debt-to-equity 0.00) -- balance sheet can absorb a shock — Risk
Bear Case
- P/E of 29.8 is moderate-to-rich — Value
- EPS declining -2.5% YoY despite any revenue growth — Growth
- MACD histogram negative -- bearish momentum — Technical
IDXX Committee View
60% agreement
5 analysts
Positive signals support the current rating — 5 consecutive earnings beats -- consistent execution. The committee sees sufficient evidence to maintain the constructive view.
Bull Case
- ROE of 72.0% shows genuine earnings power backing the valuation — Value
- 5 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
Bear Case
- P/E of 40.6 is expensive by classic value standards — Value
- Price-to-book of 33.7x prices in significant intangible value — Value